|
US5171680A
(en)
|
1988-06-14 |
1992-12-15 |
Chiron Corporation |
Superoxide dismutase analogs having novel binding properties
|
|
CA2119761C
(en)
|
1991-11-13 |
1997-12-16 |
Bjorn Dahlback |
Method for the diagnosis of blood coagulation disorders
|
|
US5670483A
(en)
|
1992-12-28 |
1997-09-23 |
Massachusetts Insititute Of Technology |
Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
|
|
JP3367581B2
(ja)
|
1993-10-14 |
2003-01-14 |
小野薬品工業株式会社 |
新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞
|
|
US6852508B1
(en)
|
1997-02-28 |
2005-02-08 |
Genetics Institute, Llc |
Chemokine with amino-terminal modifications
|
|
US6100387A
(en)
|
1997-02-28 |
2000-08-08 |
Genetics Institute, Inc. |
Chimeric polypeptides containing chemokine domains
|
|
US6214540B1
(en)
|
1997-03-26 |
2001-04-10 |
University Of Maryland Biotechnology Institute |
Chemokines that inhibit immunodeficiency virus infection and methods based thereon
|
|
CA2305787A1
(en)
|
2000-05-09 |
2001-11-09 |
The University Of British Columbia |
Cxcr4 antagonist treatment of hematopoietic cells
|
|
JP2002506830A
(ja)
|
1998-03-13 |
2002-03-05 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
治療的ケモカイン受容体アンタゴニスト
|
|
CA2245224A1
(en)
|
1998-08-14 |
2000-02-14 |
Jiang-Hong Giong |
Chemokine receptor antagonists and chemotherapeutics
|
|
US20020107195A1
(en)
|
1998-07-21 |
2002-08-08 |
Smithkline Beecham Corporation |
Method for inducing chemotaxis in endothelial cells by administering stromal cell derived factor-1alpha
|
|
US6440934B1
(en)
*
|
1998-10-13 |
2002-08-27 |
Chiron Corporation |
Angiogenically effective unit dose of FGF-2 and method of use
|
|
EE05111B1
(et)
*
|
1998-10-16 |
2008-12-15 |
Biogen, Incorporated |
Interferoon-beetaga sulandatud valgud ja nende kasutamine
|
|
US6221856B1
(en)
|
1999-02-03 |
2001-04-24 |
Inologic, Inc. |
Inositol derivatives for inhibiting superoxide anion production
|
|
AU2003901668A0
(en)
|
2003-03-28 |
2003-05-01 |
Medvet Science Pty. Ltd. |
Non-haemopoietic precursor cells
|
|
US7368425B2
(en)
|
2006-03-24 |
2008-05-06 |
Chemokine Therapeutics Corp. |
Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
|
|
US20050059584A1
(en)
|
2002-08-16 |
2005-03-17 |
Ahmed Merzouk |
Novel chemokine mimetics synthesis and their use
|
|
US7378098B2
(en)
|
2000-04-12 |
2008-05-27 |
The University Of British Columbia |
CXC chemokine receptor 4 agonist peptides
|
|
CA2335109A1
(en)
|
2000-04-12 |
2001-10-12 |
Chemokine Therapeutics Corporation |
Cxcr4 agonist treatment of hematopoietic cells
|
|
DE10027383A1
(de)
|
2000-06-02 |
2001-12-20 |
Rhein Biotech Proz & Prod Gmbh |
Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz
|
|
AU2001275339A1
(en)
|
2000-06-05 |
2001-12-17 |
The Trustees Of Columbia University In The City Of New York |
Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
|
|
US7547674B2
(en)
|
2001-06-06 |
2009-06-16 |
New York Medical College |
Methods and compositions for the repair and/or regeneration of damaged myocardium
|
|
WO2002036078A2
(en)
|
2000-11-05 |
2002-05-10 |
University Of Florida |
Targeting pluripotent stem cells to tissues
|
|
JP2004534723A
(ja)
|
2000-11-09 |
2004-11-18 |
ジェネティクス インスティテュート，エルエルシー |
腫瘍ワクチンとしてのＳＤＦ−１β発現腫瘍細胞
|
|
EP1399184A2
(en)
|
2000-12-01 |
2004-03-24 |
Schering Corporation |
Uses of mammalian genes and related reagents
|
|
WO2002045717A1
(en)
|
2000-12-06 |
2002-06-13 |
Tularik Inc. |
Lometrexol combination therapy
|
|
WO2003046833A2
(en)
|
2001-11-24 |
2003-06-05 |
Image Analysis, Inc. |
Automatic detection and quantification of coronary and aortic calcium
|
|
US20030199464A1
(en)
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
|
WO2003094950A2
(en)
|
2002-05-10 |
2003-11-20 |
Ipf Pharmaceuticals Gmbh |
A method of inhibiting the emigration of cells from the intravascular compartment into tissues
|
|
US7485141B2
(en)
|
2002-05-10 |
2009-02-03 |
Cordis Corporation |
Method of placing a tubular membrane on a structural frame
|
|
US20050065064A1
(en)
|
2002-08-09 |
2005-03-24 |
Elias Lolis |
Identification of allosteric peptide agonists of CXCR4
|
|
US20050271639A1
(en)
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
|
US20040037811A1
(en)
|
2002-08-22 |
2004-02-26 |
The Cleveland Clinic Foundation |
Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
|
|
WO2004017909A2
(en)
|
2002-08-23 |
2004-03-04 |
Bristol-Myers Squibb Company |
Methods of reducing ischemic injury
|
|
US20070060512A1
(en)
|
2003-03-04 |
2007-03-15 |
Homayoun Sadeghi |
Dipeptidyl-peptidase protected protein
|
|
WO2004094465A2
(en)
|
2003-04-23 |
2004-11-04 |
The Board Of Trustees Of The University Of Illinois Office Of Technology Management University Of Illinois At Urbana-Champaign |
Synthetic molecules that mimic chemokines
|
|
US7776564B2
(en)
|
2004-04-30 |
2010-08-17 |
Five Prime Therapeutics, Inc. |
Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use
|
|
JP5031370B2
(ja)
|
2004-09-17 |
2012-09-19 |
セルジェンテック株式会社 |
外用皮膚潰瘍治療剤
|
|
KR20130100225A
(ko)
|
2004-09-24 |
2013-09-09 |
안지오블라스트 시스템스 인코퍼레이티드 |
간엽 전구세포의 증식 및/또는 생존성 증강 방법
|
|
WO2006047315A2
(en)
|
2004-10-25 |
2006-05-04 |
The Brigham And Women's Hospital, Inc. |
Targeted delivery of biological factors using self-assembling peptide nanofibers
|
|
US20060110374A1
(en)
|
2004-11-24 |
2006-05-25 |
Dudy Czeiger |
Method to accelerate stem cell recruitment and homing
|
|
JP2008526749A
(ja)
|
2005-01-04 |
2008-07-24 |
ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド |
自己アセンブリするペプチドナノファイバーを用いたｐｄｇｆの徐放性の送達
|
|
US8153592B2
(en)
|
2005-01-10 |
2012-04-10 |
Mayo Foundation For Medical Education And Research |
Modulating toll-like receptor activity
|
|
KR20080007380A
(ko)
|
2005-04-25 |
2008-01-18 |
메사추세츠 인스티튜트 오브 테크놀로지 |
지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및방법
|
|
KR20080060226A
(ko)
*
|
2005-10-31 |
2008-07-01 |
라보라토리스 세로노 에스.에이. |
신경 질환의 치료 및/또는 예방을 위한 ｓｄｆ-1의 용도
|
|
WO2007079460A2
(en)
|
2006-01-04 |
2007-07-12 |
Chemokine Therapeutics Corporation |
Design of cxc chemokine analogs for the treatment of human diseases
|
|
US7776816B2
(en)
*
|
2006-01-20 |
2010-08-17 |
Board Of Regents, The University Of Texas System |
Preserving hypoxic tissue
|
|
ES2396220T3
(es)
|
2006-08-11 |
2013-02-20 |
Ono Pharmaceutical Co., Ltd. |
Anticuerpos monoclonales frente al factor 1 derivado del estroma (SDF-1)
|
|
US7696309B2
(en)
|
2006-10-23 |
2010-04-13 |
The Brigham And Women's Hospital, Inc. |
Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
|
|
US20080194478A1
(en)
|
2007-02-09 |
2008-08-14 |
Gene Signal International Sa |
Wound healing agent and composition
|
|
AU2008232739B2
(en)
|
2007-03-30 |
2014-03-27 |
The Cleveland Clinic Foundation |
Method of treating ischemic disorders
|
|
ES2325715B1
(es)
|
2007-08-03 |
2010-06-17 |
Genetrix, S.L. |
Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
|
|
US8414924B2
(en)
|
2007-10-10 |
2013-04-09 |
Kyoto University |
Preparation for treating heart disease used in cell therapy
|
|
WO2009060608A1
(ja)
*
|
2007-11-07 |
2009-05-14 |
Ono Pharmaceutical Co., Ltd. |
Ｓｄｆ－１を含有してなる徐放性組成物
|
|
EP2100954A1
(en)
|
2008-03-10 |
2009-09-16 |
Assistance Publique - Hopitaux de Paris |
Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications
|
|
JPWO2010024300A1
(ja)
|
2008-08-26 |
2012-01-26 |
国立大学法人北海道大学 |
骨充填型軟骨組織再生誘導剤
|
|
US9072765B2
(en)
|
2009-05-20 |
2015-07-07 |
Board Of Regents, The University Of Texas System |
Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure
|
|
WO2010138180A2
(en)
*
|
2009-05-26 |
2010-12-02 |
The University Of Vermont And State Agriculture College |
Compositions and methods for cardiac tissue repair
|
|
US9308277B2
(en)
|
2010-02-25 |
2016-04-12 |
Mesoblast International Sàrl |
Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
|
|
WO2012027170A1
(en)
*
|
2010-08-23 |
2012-03-01 |
Provasculon, Inc. |
Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
|
|
EP2610752B1
(en)
*
|
2010-08-27 |
2017-09-27 |
Fujitsu Limited |
Parallel computer, job information acquisition program of parallel computer, and job information acquisition method for parallel computer
|
|
AU2012268078B2
(en)
|
2011-06-07 |
2017-06-01 |
Mesoblast International Sarl |
Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived Factor-1
|
|
SG11201604793YA
(en)
|
2013-12-13 |
2016-07-28 |
Mesoblast Internat Sarl |
Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
|